World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 13 May 2013
Main ID:  NCT00940277
Date of registration: 14/07/2009
Primary sponsor: Fox Chase Cancer Center
Public title: Couple-Focused Intervention for Breast Cancer Patients
Scientific title: Couple-Focused Group Intervention for Women With Early-Stage Breast Cancer
Date of first enrolment: December 2007
Target sample size: 852
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00940277
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care  
Countries of recruitment
United States
Contacts
Name:   Sara M Frederick
Address: 
Telephone: 215-214-3794
Email: sara.worhach@fccc.edu
Affiliation: 
Name:   Sharon L Manne, PhD
Address: 
Telephone:
Email:
Affiliation:  Fox Chase Cancer Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- patient has a primary diagnosis of Stage 0 (Ductal Carcinoma in situ), 1, 2, or 3a
breast cancer

- patient has had breast cancer surgery within the last twelve months

- patient and partner married or cohabitating

- patient and partner 18 years of age or older

- patient and partner speak and read English

- patient and partner can provide meaningful informed consent

- patient and partner do not have any chronic physical or cognitive illness that would
preclude participation in the group sessions

- couple lives within 2 hour commuting distance to the center from which they are
recruited

Exclusion criteria:

- patient is male



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Breast Cancer
Intervention(s)
Behavioral: Group Counseling
Primary Outcome(s)
Impact of Events Scale-Revised [Time Frame: baseline, 1 week post-intervention, 6 mos post-intervention, 12 mos post-intervention]
Mental Health Inventory [Time Frame: time of consent/baseline, 1 week post-intervention, 6 months post-intervention, 12 months post-intervention]
Well-being Subscale of the Mental Health Inventory (MHI) [Time Frame: baseline, 1 wk post-intervention, 6 mos post-intervention, 12 mos post-intervention]
Secondary Outcome(s)
Adherence to Chemotherapy [Time Frame: 1 yr follow-up]
Adherence to Radiation Therapy [Time Frame: 1 yr follow-up]
Mental Outcomes Survey (MOS SF-36) [Time Frame: baseline, 1 wk post-intervention, 6 mos post-intervention, 12 mos post-intervention]
Secondary ID(s)
CA-65727
IRB#07-831
R01CA078084-07
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Abington Memorial Hospital
Albert Einstein College of Medicine of Yeshiva University
Christiana Care Health Services
National Cancer Institute (NCI)
The City University of New York
The Cooper Health System
Virtua Health
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history